Survey explores effects of prostate cancer on intimacy

A new Irish study funded by the Irish Cancer Society exposes how prostate cancer patients and their partners often lack preparation for the impact of treatment on their sexual function. Approximately 4,000 men are diagnosed with prostate cancer annually in Ireland, which means about one in seven men will receive a diagnosis during their lifetime.

The PRO-ACT (Patient-led Research On sexual experience After Cancer Treatment) survey involved 1,150 patients and partners. Key findings reveal that 40% of respondents felt unprepared for the treatment's impact on sexual function, with 60% reporting the consequences were worse or much worse than anticipated.

The research highlights the need for more comprehensive discussions with medical teams to better prepare patients for sexual consequences. Martin Sweeney, a prostate cancer patient and Co-Chief Investigator of PRO-ACT, expressed that in 66% of cases, patients were underprepared for the sexual repercussions of treatment. Sweeney, diagnosed at 49, opted for a radical procedure that adversely affected his sexual function, urinary control, and mental health.

Despite the challenges, including strained relationships with his partner, Sweeney emphasized the importance of clearer information from medical professionals.

Dr. Claire Kilty, Head of Research at the Irish Cancer Society, pointed out that cultural taboos surrounding sexual function and intimacy often deter individuals from discussing these issues with partners, family, or healthcare providers. She stressed the importance of listening to partners, who frequently offer crucial emotional and practical support.

Kilty suggested that while clinicians focus on saving lives, there is a growing need to address patient experiences, including their quality of life after prostate cancer treatment.